Cancer Therapy News and Research

RSS

Major UK study launched to assess the impact of COVID-19 on cancer patients

A new UK study has been launched to assess the impact of covid-19 on people with cancer.

2 Sep 2020

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).

2 Sep 2020

Study: BIRC2 overexpression could be a key marker for immunotherapy resistance

Johns Hopkins Medicine researchers have added to evidence that a gene responsible for turning off a cell's natural "suicide" signals may also be the culprit in making breast cancer and melanoma cells resistant to therapies that use the immune system to fight cancer.

2 Sep 2020

New microgel drug delivery method could improve effectiveness of pancreatic islet transplants

Pancreatic islet transplants, which revive insulin production to treat type 1 diabetes, only last an average of three years.

31 Aug 2020

Virginia Tech researcher wins NIH award to study possible treatments for metastatic breast cancer

Eli Vlaisavljevich, an assistant professor of biomedical engineering and mechanics at Virginia Tech, received a Trailblazer Award from the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health to research possible treatments for metastatic breast cancer.

28 Aug 2020

Prosthetic breast reconstruction outcomes do not deteriorate over time, shows study

Breast reconstruction is an important option for women undergoing mastectomy, and a two-stage approach using implants is by far the most common reconstruction technique.

28 Aug 2020

Environmental surface testing at radiation oncology clinic showed no detectable SARS-CoV2

A Rutgers Cancer Institute of New Jersey study shows environmental surface testing at the center's Radiation Oncology Department located within Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, during the height of the COVID-19 pandemic in the state showed no detectable SARS-CoV2 – the virus that causes COVID-19

28 Aug 2020

New diagnostic tool can predict cancer patients' response to immunotherapy

A new diagnostic tool that can predict whether a cancer patient would respond to immunotherapy treatment has been developed by scientists at the University of Bath.

27 Aug 2020

Researchers discover new genes that influence cancer treatment success

One of the great mysteries of cancer research is why certain patients respond better to radiation therapy than others. Researchers at the University of Bern have now discovered which genes play an important role in this. This results in new findings for cancer treatment.

25 Aug 2020

Delivering split immunotoxins separately to cancer cells can reduce life-threatening side effects

Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests.

25 Aug 2020

Researchers identify potential drug target for curtailing cancer metastasis

Researchers led by Ludwig Chicago Co-director Ralph Weichselbaum and Ronald Rock of the University of Chicago have identified in preclinical studies a potential drug target for curtailing cancer metastasis.

24 Aug 2020

Researchers find a new way to slow colon cancer metastasis

When cancer metastasizes and spreads throughout the body, it can severely change the prognosis of the disease. It is estimated that metastasis is responsible for 90 percent of cancer deaths.

24 Aug 2020

Study examines the effects of cancer and its treatment on aging process

A new study examines the effects of cancer and its treatment on the aging process. Investigators found that expression of a gene associated with aging is higher in young patients with cancer after treatment with chemotherapy and in young cancer survivors who are frail.

24 Aug 2020

New bioluminescent reporter developed to track DNA double stranded break repair

A new bioluminescent reporter that tracks DNA double stranded break repair in cells has been developed by researchers from Massachusetts General Hospital and the Academia Sinica in Taiwan.

21 Aug 2020

Key molecule can be used to assess prognosis of triple negative breast cancer

Hokkaido University scientists have shown that Interleukin-34 is a prognostic marker and drug target for Triple Negative Breast Cancer.

21 Aug 2020

Using engineered off-the-shelf therapeutic T cells to fight cancer

Personalized cancer treatments are no longer just options of the future. In the past few years, researchers have made significant progress in 'teaching' the body's immune T cells to recognize and kill specific cancer cells, and human clinical trials have shown that this approach can successfully eliminate tumors.

20 Aug 2020

A metabolic enzyme shows great potential as target for immunotherapies

The metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system.

20 Aug 2020

Drug used in rheumatoid arthritis and cancer treatment improves survival in critically ill COVID-19 patients

Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in rheumatoid arthritis and cancer treatments, tocilizumab, improves hospital survival in critically-ill patients admitted to the intensive care unit (ICU).

20 Aug 2020

Microbial diversity can improve treatment for cancer patients

Physicians at City of Hope, working in collaboration with scientists at Translational Genomics Research Institute (TGen), have found that greater gut microbial diversity in patients with metastatic kidney cancer is associated with better treatment outcomes on Food and Drug Administration-approved immunotherapy regimens.

19 Aug 2020

Researchers receive funding to develop a model for delivering palliative care in nursing homes

Research scientists from Regenstrief Institute, Indiana University School of Medicine and University of Maryland are working to develop a model for delivering palliative care to people living in nursing homes to improve their quality of life.

17 Aug 2020

Cancer Therapy News and Research

Major UK study launched to assess the impact of COVID-19 on cancer patients

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

Study: BIRC2 overexpression could be a key marker for immunotherapy resistance

New microgel drug delivery method could improve effectiveness of pancreatic islet transplants

Virginia Tech researcher wins NIH award to study possible treatments for metastatic breast cancer

Prosthetic breast reconstruction outcomes do not deteriorate over time, shows study

Environmental surface testing at radiation oncology clinic showed no detectable SARS-CoV2

New diagnostic tool can predict cancer patients' response to immunotherapy

Researchers discover new genes that influence cancer treatment success

Delivering split immunotoxins separately to cancer cells can reduce life-threatening side effects

Researchers identify potential drug target for curtailing cancer metastasis

Researchers find a new way to slow colon cancer metastasis

Study examines the effects of cancer and its treatment on aging process

New bioluminescent reporter developed to track DNA double stranded break repair

Key molecule can be used to assess prognosis of triple negative breast cancer

Using engineered off-the-shelf therapeutic T cells to fight cancer

A metabolic enzyme shows great potential as target for immunotherapies

Drug used in rheumatoid arthritis and cancer treatment improves survival in critically ill COVID-19 patients

Microbial diversity can improve treatment for cancer patients

Researchers receive funding to develop a model for delivering palliative care in nursing homes

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News